With its U.S. headquarters located within the Germantown Innovation Center, Epigenomics recently announced that its blood-based test for colorectal cancer screening, Epi proColon®, will be available in the U.S. This deal is yet another example of the success of a company in Montgomery County’s Business Innovation Network, specifically in the life sciences incubator, earning significant revenue from the marketplace. Read more.